"Gwarantujemy: świadczenia zdrowotne, profilaktyczne, diagnostyczne, lecznicze i pielęgnacyjne z zakresu medycyny rodzinnej, chorób wewnętrznych i pediatrii."

During the past decade, AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Chronic Heart Failure With Reduced Ejection Fraction" (1 trials), "Dyslipidemias" (1 trials), "Familial Hypercholesterolemia" (1 trials) and "High Cholesterol" (1 trials). Many other conditions were trialed in "AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia" in a lesser frequency.

Most popular intervention types in "AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "IONIS-AGT-LRx" (1 trials) and "Obicetrapib" (1 trials). Other intervention names were less common.

The vast majority of trials in "AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AKA-MED Centrum Spólka z Ograniczona Odpowiedzialnoscia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".